Compositions and methods for the biosynthesis of vanillin or vanillin beta-d-glucoside

US11008592B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11008592-B2
Application numberUS-201916243670-A
CountryUS
Kind codeB2
Filing dateJan 9, 2019
Priority dateAug 8, 2011
Publication dateMay 18, 2021
Grant dateMay 18, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Recombinant microorganisms, plants, and plant cells are disclosed that have been engineered to express a mutant AROM polypeptide and/or mutant catechol-O-methyltransferase polypeptide alone or in combination with one or more vanillin biosynthetic enzymes or UDP-glycosyltransferases (UGTs). Such microorganisms, plants, or plant cells can produce vanillin or vanillin beta-D-glucoside.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for producing vanillin and/or vanillin beta-D-glucoside comprising (a) providing a recombinant host capable of producing vanillin, wherein said recombinant host harbors a heterologous nucleic acid encoding a mutant Catechol-O-Methyl Transferase (COMT) polypeptide, wherein the mutant COMT polypeptide comprises 1 to 10 amino acid substitutions in the amino acid sequence set forth in SEQ ID NO:27; (b) cultivating said recombinant host for a time sufficient for said recombinant host to produce vanillin and/or vanillin glucoside; and (c) isolating vanillin and/or vanillin glucoside from said recombinant host or from the cultivation supernatant, thereby producing vanillin and/or vanillin beta-D-glucoside. 2. The method of claim 1 , wherein the mutant COMT polypeptide is capable of catalyzing methylation of an —OH group of protocatechuic acid, wherein said methylation results in generation of at least 4 times more vanillic acid compared to iso-vanillic acid. 3. The method of claim 1 , wherein the mutant COMT polypeptide comprises an amino acid having a lower hydropathy index than leucine at position 198 of SEQ ID NO:27. 4. The method of claim 1 , wherein the mutant COMT polypeptide comprises Ala, Arg, Asn, Asp, Cys, Glu, Gln, Gly, His, Lys, Met, Phe, Pro, Ser, Thr, Trp and Tyr at position 198 of SEQ ID NO:27. 5. The method of claim 1 , wherein the mutant COMT polypeptide comprises an amino acid which has either a neutral or positive side-chain charge at pH 7.4 at position 199 of SEQ ID NO:27. 6. The method of claim 1 , wherein the mutant COMT polypeptide comprises Ala, Arg, Asn, Cys, Gln, Gly, His, Ile, Leu, Lys, Met, Phe, Pro, Ser, Thr, Trp, Tyr and Val at position 199 of SEQ ID NO:27. 7. The method of claim 1 , wherein the mutant COMT polypeptide further comprises a purification tag, a chloroplast transit peptide, a mitochondrial transit peptide, an amyloplast peptide, signal peptide, or a secretion tag at the N or C-terminus of said polypeptide. 8. The method of claim 1 , wherein said host is a microorganism. 9. The method of claim 1 , wherein said host is Saccharomyces cerevisiae, Schizosaccharomyces pombe or Escherichia coli. 10. The method of claim 1 , wherein said host is S. cerevisiae comprising a deletion of pdc1, a deletion of gdh1, and overexpressing glutamate dehydrogenase 2 (GHD2). 11. The method of claim 1 , wherein said host is a plant or plant cell. 12. The method of claim 1 , wherein said host is a Physcomitrella or tobacco plant or plant cell. 13. The method of claim 1 , wherein said host further comprises a gene encoding a 3-dehydroshikimate dehydratase (3DSD), a gene encoding an aromatic carboxylic acid reductase (ACAR), a gene encoding a uridine 5′-diphosphoglucosyl transferase (UGT), a gene encoding a phosphopantetheine transferase (PPTase) and/or a gene encoding a vanillyl alcohol oxidase (VAC)). 14. The method of claim 1 , wherein said host further comprises a gene encoding a wild-type O-methyltransferase (OMT).

Assignees

Inventors

Classifications

  • C12P7/24Primary

    containing a carbonyl group · CPC title

  • Shikimate dehydrogenase (1.1.1.25) · CPC title

  • Catechol O-methyltransferase (2.1.1.6) · CPC title

  • acting on CH-OH groups as donors (1.1) · CPC title

  • Catechol O-methyltransferase (2.1.1.6) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11008592B2 cover?
Recombinant microorganisms, plants, and plant cells are disclosed that have been engineered to express a mutant AROM polypeptide and/or mutant catechol-O-methyltransferase polypeptide alone or in combination with one or more vanillin biosynthetic enzymes or UDP-glycosyltransferases (UGTs). Such microorganisms, plants, or plant cells can produce vanillin or vanillin beta-D-glucoside.
Who is the assignee on this patent?
Int Flavors & Fragrances Inc, Evolva Sa
What technology area does this patent fall under?
Primary CPC classification C12P7/24. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).